Bioporto AS (LTS:0JJM) Total Equity: kr63.01 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0JJM Bioporto AS LTS:0JJM
70 GF Score
Price kr1.22
GF Value kr1.33
! 4 Warning Signs
View Full Analysis

What is Bioporto AS Total Equity?

Bioporto AS LTS:0JJM 70 Total Equity is kr63.01 Mil as of Dec. 2025. GuruFocus rates LTS:0JJM with a GF Score™ of 70/100 and a GF Value™ of kr1.33. The stock has 4 warning signs investors should review.

Bioporto AS's total equity for the quarter that ended in Dec. 2025 was kr63.01 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bioporto AS Total Equity Historical Data

* Premium members only.

The historical data trend for Bioporto AS's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioporto AS Total Equity Chart

Bioporto AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.96 70.22 60.16 67.75 63.01

Bioporto AS Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.75 41.44 57.22 35.18 63.01
LTS:0JJM
70GF Score
Bioporto AS LTS:0JJM
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioporto AS Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bioporto AS's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=93.182-30.173
=63.01

Bioporto AS's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=93.182-30.173
=63.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr63.01 Mil mean?
Bioporto AS (LTS:0JJM) has a Total Equity of kr63.01 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Bioporto AS and its competitors.
Is Bioporto AS's Total Equity too high?
Bioporto AS's current Total Equity is kr63.01 Mil. Overall, Bioporto AS has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Bioporto AS's Total Equity compare to TMO and DHR?
Bioporto AS's Total Equity of kr63.01 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Diagnostics & Research company?
A good Total Equity depends on the Medical Diagnostics & Research industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bioporto AS and its competitors. Bioporto AS's current Total Equity is kr63.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioporto AS stock overvalued right now?
Bioporto AS (LTS:0JJM) has a current Total Equity of kr63.01 Mil. The stock's GF Value™ is kr1.33, compared to a current price of kr1.22 — trading 8.1% below its estimated fair value. The current Total Equity is kr63.01 Mil. Bioporto AS's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bioporto AS (LTS:0JJM), the current Total Equity is kr63.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioporto AS (LTS:0JJM) Overvalued in 2026?

Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued. The current stock price of kr1.22 is trading 8.1% below its estimated GF Value™ of kr1.33.

Key valuation signals for LTS:0JJM:

  • Total Equity: kr63.01 Mil
  • GF Value™: kr1.33 vs. price of kr1.22 (8.1% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the LTS:0JJM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bioporto AS Business Description

Other Exchanges BIOPOR:Denmark
Address Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.
70GF Score

Get the complete analysis for LTS:0JJM

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.22
Price
kr1.33
GF Value